42 /100
MEDIUM RISK
Score updated Jul 13, 2026

HKPD — Cellyan Biotechnology Co., Ltd Dilution Risk Tracker

Track HKPD dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track HKPD — Get alerts when the score changes →

As of July 13, 2026, Cellyan Biotechnology Co., Ltd (HKPD) has a DilutionWatch DilutionScore of 42/100, rated MEDIUM dilution risk. Cellyan Biotechnology Co., Ltd has a market capitalization of $12.34M, 11.00M shares outstanding, 4 institutional holders tracked.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
52
💰 Cash Runway
40
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.61 below $1 exchange minimum
🔔 Track HKPD — Get forecast alerts →

💹 Market Data

Market Cap$12.34M
Shares Outstanding11.00M
Float7.36M
Cash$2.48M
Debt$2.27M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 15.3% shares (2026Q1 vs prior)
4 institutional holders · 62.4K shares
#1 StoneX Group Inc. 39.4K shares
#2 Clear Street Group Inc. 12.0K shares
#3 TWO SIGMA INVESTMENTS, LP 10.8K shares
+ 1 more holders Sign up free to view →

📉 Short Interest

Short Interest164.6K
Days to Cover2.3
% of Float2.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

No recent SEC insights

📰 Recent News

No recent news

📋 What This Means for HKPD Shareholders

Cellyan Biotechnology Co., Ltd (HKPD) has a DilutionScore of 42/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for HKPD shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for HKPD in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for HKPD alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track HKPD Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking HKPD — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for HKPD
📊 HKPD FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 HKPD Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.